Skip to main content
Award Ceremony, SxDiagnostics
The two founders, Carolyn Krause (l) and Susanne Schmidt (r) at the award ceremony, with Heike Marzen, Managing Director of the Dortmund Economic Development Agency and Alexander Kalouti, Mayor of the City of Dortmund
© Wirtschaftsförderung Dortmund / Andreas Buck

News categories: Honors & Funding

start2grow start-up competition awards “SxDiagnostics”

The “SxDiagnostics” project from the University of Bonn and the University Hospital Bonn (UKB) prevailed against over 100 competing teams in the start2grow competition and placed in the (shared) 4th to 10th spots. Start2grow is organized nationwide by the Dortmund Economic Development Agency and celebrated its 25th anniversary this year.

“SxDiagnostics,” led by Dr. Susanne Schmidt and Carolyn Krause, will use the prize money to further develop its innovative “SIRS chip” for detecting certain inflammatory responses towards market-readiness. This blood-based method can be used to assess the risk of systemic inflammatory response syndrome (SIRS). SIRS is a life-threatening immune response that can occur after invasive surgery and lead to death. The resulting SIRS prognosis helps physicians implement advanced therapies against SIRS prior to surgery, thereby saving lives.

Start-up Momentum from the Medical Field

“We were thrilled to receive the start2grow award! Now we’re highly motivated to continue working on our business and financing plans and are looking for business administrators, sales professionals, lawyers, and regulatory experts who can actively support us in building our start-up,” says Dr. Susanne Schmidt. She heads the Immune Monitoring & Genomics working group at the Institute of Clinical Chemistry and Clinical Pharmacology at the UKB. With her start-up project, she has already secured a GO-Bio initial grant from the BMFTR and a prototyping grant from the University of Bonn in 2025. The transfer teams from the Transfer Center enaCom and the Faculty of Medicine are supporting her on her path to founding the company.

Awards Ceremony in Dortmund

For the grand finale of start2grow 2025, held in Dortmund in March 2026, 20 selected teams were invited to present their business models to a panel of experts from the business, academic, and financial sectors. Among the top 10 teams, SxDiagnostics is the only one from the medical field. The top three spots went to the start-ups Spree Monitoring GmbH—a monitoring system for bridges—cargovibe UG—solutions for truck drivers—and wailand—an AI platform for engineers. All participants are supported by experienced coaches and benefit from expert knowledge, networks, and a variety of events.

About start2grow

The nationwide start-up competition start2grow, organized by the Dortmund Economic Development Agency, supports founders and start-ups with innovative and technology-driven business models.

Contact

Dr. Susanne Schmidt
Institute of Clinical Chemistry and Clinical Pharmacology
University Hospital Bonn (UKB)
mail: susanne.schmidt@uni-bonn.de
phone: +49 228 28712102

website SxDiagnostics

Related news

Prof. Dr. Elvira Mass (left) and Prof. Dr. Tatjana Tchumatchenko (right)

News categories: Honors & Funding

Hunting for New Angles

New research questions often arise where different methods, mindsets and subject-specific cultures meet, and it is these kinds of encounter that Professor Elvira Mass and Professor Tatjana Tchumatchenko want to make happen in a targeted way in future. The two researchers have been picked as Henriette Herz Scouts by the Alexander von Humboldt Foundation.
View entry
Precise Konsortium

News categories: Publication Honors & Funding

Making Cancer Cells More Predictable: PRECISE Aims to Forecast Therapeutically Actionable Vulnerabilities

Which genes and signaling pathways does a cancer cell require to survive? And which of these could serve as therapeutic targets? The pan-European initiative PRECISE aims to identify such vulnerabilities not only through labor-intensive laboratory experiments but also by predicting them using computational models. The UKB and the University of Bonn, represented by Prof. Dr. Maximilian Billmann and Prof. Dr. Jonathan Schmid-Burgk, are among the founding partners of the consortium. The scientific vision of the initiative has now been published in a commentary in Nature Genetics.
View entry
Prof. Dr. Jörg Wenzel

News categories: Honors & Funding

Jörg Wenzel elected chair of EADV Task Force on Cutaneous Lupus Erythematosus (CLE)

The European Academy of Dermatology and Venereology (EADV) has establishment a new Task Force on Cutaneous Lupus Erythematosus (CLE), led by ImmunoSensation³ member Jörg Wenzel. CLE, as autoimmune disease of the skin, is a prime example of chronic inflammatory dysregulation, leading to a severe disease burden. The treatment of cutaneous lupus continues to face unresolved clinical challenges. The CLE Task Force is set up to push the boundaries of clinical care, update guidelines, and advance collaborative research across Europe.
EADV Task Forces

Back to the news overview